India has suspended all major exports of the AstraZeneca-Oxford vaccine from the Serum Institute of India, SII.

This unfortunate and shocking move by India came as the European Union met on Thursday to consider giving member states greater scope to block vaccines being exported outside the bloc, much of which is struggling to bring infections down and ramp up immunisation campaigns.

At the moment, It is not known how long the suspension will last, but health watchers say the development is likely to delay the delivery of the nation’s 2nd batch of vaccine supplies expected around the end of March and early April.

The suspension could also delay supplies to other African countries as well as several low and middle-income countries that are relying on India’s production and supply of Covishield